Lawmakers are trying to restore access to GLP-1 weight loss drugs, like Ozempic and Wegovy, after Ohio removed medical ...

Cheaper versions of medications to treat obesity, like Ozempic and Wegovy, could be on the market in Canada as soon as ...

People who take GLP-1 drugs like Ozempic can lose weight even if they face disruptions in accessing the medications, which ...

According to a new report from Big Chalk Analytics, GLP-1 users have cut $6.5 billion from U.S. grocery spend.

Offering a rare glimpse inside the hidden world of rejected insurance claims, new data shows a steady uptick among major ...

The Canadian researcher has just received the Frontiers of Knowledge Award for his work on anti-obesity drugs. However, he ...

Pennsylvania Governor Josh Shapiro's office has said it is looking to change eligibility for weight loss drugs as part of its ...

Ozempic could help with his as a study by Goldman Sachs found that the mass-adoption of GLP-1 series drugs could allow for large-scale economic growth and increase the United States Gross Domestic ...

Would you get a one-time genetic modification such that you'd never have to take a GLP-1 drug for weight loss ever again?

School districts across Minnesota are struggling to contain double-digit health insurance cost increases. Some officials say ...

6 ways employers can lower healthcare costs in 2025 “Employers have absorbed the majority of cost increases over the past four years, and they likely cannot continue to do so,” one expert said.

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...